Skip to main content
Signal8

Elmaliah Oren

SEC insider (Form 3/4/5 filer). CIK 0001713701. Interim CFO at Nasus Pharma Ltd (NSRX) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Dec 15, 2025. Located in TEL-AVIV-YAFO.

Companies Elmaliah Oren has filed insider reports for

  • Nasus Pharma Ltd (NSRX): Officer, Interim CFO
  • My Size, Inc. (MYSZ): Officer, Chief Financial Officer
Elmaliah Oren profile photo

Elmaliah Oren

CIK: 0001713701

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Nasus Pharma Ltd logo
NSRX

Nasus Pharma Ltd

Officer
My Size, Inc. logo
MYSZ

My Size, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • My Size, Inc. logo
    MYSZ

    My Size, Inc.

    Dec 15, 2025
    Award
    Direct
    30K shares-
  • My Size, Inc. logo
    MYSZ

    My Size, Inc.

    Jun 4, 2025
    Disposition

    Option to purchase Common Stock (right to buy)

    Direct
    150 shares-
  • My Size, Inc. logo
    MYSZ

    My Size, Inc.

    Jun 4, 2025
    Award

    Option to purchase Common Stock (right to buy)

    Direct
    150 shares-

1-3 of 3